VEGFA and cancer: Although anti-angiogenic therapies, such as anti-VEGF antibodies, are prescribed to inhibit neovascularization and decrease the blood supply needed for growth in various types of cancer, the results have been disappointing in highly invasive and aggressive cancers, including ovarian cancer.